Circulation, Vol 82, 369-375, Copyright © 1990 by American Heart Association
P Nihoyannopoulos, PM Gomez, J Joshi, S Loizou, MJ Walport and CM Oakley
Two-dimensional echocardiographic studies were prospectively performed in
93 patients with systemic lupus erythematosus (SLE) to discover the
incidence and spectrum of cardiac abnormalities and to relate these
findings to the presence of high levels of anticardiolipin antibodies.
Assessment of the intracardiac anatomy was also performed in an additional
12 patients who had increased anticardiolipin antibody levels but did not
have SLE. Fifty patients (54%) with SLE had cardiac abnormalities, and 43
patients (46%) had normal hearts. Three categories of cardiac abnormalities
were identified--valvular lesions, ranging from vegetations to valvular
thickening, were found in 28%, pericardial effusion or thickening was found
in 20%, and regional or global left ventricular dysfunction was found in
5%. High levels of anticardiolipin antibodies were detected in 50 patients
(54%) with SLE. Of those, only 11 (22%) had an entirely normal heart,
whereas the remaining 39 (78%) had at least one cardiac abnormality
(valvular lesions in 20, pericardial effusion in 15, and myocardial
dysfunction in five patients). In patients with SLE, the presence of
abnormal intracardiac anatomy was strongly associated with increased levels
of anticardiolipin antibodies (p less than 0.0001). The overall sensitivity
and specificity of high levels of anticardiolipin antibodies in the
prediction of cardiac abnormalities was 78% and 74%, respectively, with a
positive predictive accuracy of 78% and a negative predictive accuracy of
74%. Eight of the 12 patients (67%) who had increased anticardiolipin
antibodies but whose disease did not fulfill the American Rheumatism
Association classification criteria for SLE had cardiac abnormalities
similar to those in patients with SLE compared with only four (33%) who had
normal hearts (p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies
Department of Medicine, Hammersmith Hospital, London, UK.
This article has been cited by other articles:
 |
|
 |
|
  S. C. Plastiras, C. A. Pamboucas, M. Tektonidou, and S. T. Toumanidis Real-time three-dimensional echocardiography in evaluating Libman-Sacks vegetations Eur J Echocardiogr, November 28, 2009; (2009) jep172v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Jain and M K Halushka Cardiac pathology of systemic lupus erythematosus J. Clin. Pathol., July 1, 2009; 62(7): 584 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Abdel-Aty, N Siegle, A Natusch, E Gromnica-Ihle, R Wassmuth, R Dietz, and J Schulz-Menger Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach Lupus, June 1, 2008; 17(6): 561 - 567. [Abstract] [PDF]
|
|
|
|
 |
|
 M. J. Roman and J. E. Salmon Cardiovascular Manifestations of Rheumatologic Diseases Circulation, November 13, 2007; 116(20): 2346 - 2355. [Full Text] [PDF]
|
|
|
|
|
|
H. Yamamoto, T. Iwade, R. Nakano, M. Mohri, Y. Amari, and M. Noma Numerous Small Vegetations Revealing Libman-Sacks Endocarditis in Catastrophic Antiphospholipid Syndrome Circulation, November 13, 2007; 116(20): e531 - e535. [Full Text] [PDF]
|
|
|
|
|
|
J. Pieretti, M. J. Roman, R. B. Devereux, M. D. Lockshin, M. K. Crow, S. A. Paget, J. E. Schwartz, L. Sammaritano, D. M. Levine, and J. E. Salmon Systemic Lupus Erythematosus Predicts Increased Left Ventricular Mass Circulation, July 24, 2007; 116(4): 419 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Peregud-Pogorzelska, J. Kazmierczak, and Z. Kornacewicz-Jach Heart Failure in Systemic Lupus Erythematosus Treated by Cardiac Resynchronization: A Case Report Angiology, April 1, 2007; 58(2): 238 - 241. [Abstract] [PDF]
|
|
|
|
 |
|
 I. S. Abu Romeh, A. K. Chhatriwalla, F. A. Atik, D. L. Bhatt, and J. L. Navia Myocardial Infarction Secondary to a Coronary Ostial Thrombus in Antiphospholipid Syndrome Ann. Thorac. Surg., March 1, 2007; 83(3): 1170 - 1171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. L. Nelson and P. A. Thompson Cardiovascular dysfunction in dogs associated with critical illnesses. J. Am. Anim. Hosp. Assoc., September 1, 2006; 42(5): 344 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. P. de Godoy, M. F. de Godoy, and D. M. Braile Recurrent Thrombosis in Patients with Deep Vein Thrombosis and/or Venous Thromboembolism Associated with Anticardiolipin Antibodies Angiology, January 1, 2006; 57(1): 79 - 83. [Abstract] [PDF]
|
|
|
|
|
|
F Tenedios, D Erkan, and M D Lockshin Cardiac involvement in the antiphospholipid syndrome Lupus, September 1, 2005; 14(9): 691 - 696. [Abstract] [PDF]
|
|
|
|
 |
|
 T. A. Lalani, J. P. Kanne, G. A. Hatfield, and P. Chen Imaging Findings in Systemic Lupus Erythematosus RadioGraphics, July 1, 2004; 24(4): 1069 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Sastre-Garriga and X Montalban APS and the brain Lupus, December 1, 2003; 12(12): 877 - 882. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Kudo, F. Yamasaki, T. Doi, Y. Doi, and T. Sugiura Clinical Significance of Low Voltage in Asymptomatic Patients With Pericardial Effusion Free of Heart Disease Chest, December 1, 2003; 124(6): 2064 - 2067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M E Evangelopoulos, M Alevizaki, S Toumanidis, D Sotou, C D Evangelopoulos, D A Koutras, S F Stamatelopoulos, and M Mavrikakis Mitral valve prolapse in systemic lupus erythematosus patients: clinical and immunological aspects Lupus, April 1, 2003; 12(4): 308 - 311. [Abstract] [PDF]
|
|
|
|
|
|
B. Lagana, L. Baratta, L. Tubani, V. Golluscio, M. Delfino, and F. R. Fanelli Myocardial Infarction with Normal Coronary Arteries in a Patient with Primary Antiphospholipid Syndrome: Case Report and Literature Review Angiology, November 1, 2001; 52(11): 785 - 788. [Abstract] [PDF]
|
|
|
|
 |
|
 M G Tektonidou, J P A Ioannidis, I Moyssakis, K A Boki, V Vassiliou, P G Vlachoyiannopoulos, M K Kyriakidis, and H M Moutsopoulos Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome Ann Rheum Dis, January 1, 2001; 60(1): 43 - 48. [Abstract] [Full Text]
|
|
|
|
|
|
M Turiel, S Muzzupappa, B Gottardi, C Crema, P Sarzi-Puttini, and E Rossi Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography Lupus, July 1, 2000; 9(6): 406 - 412. [Abstract] [PDF]
|
|
|
|
|
|
M. Fernandes de Godoy, D. M. Braile, C. A. A. Torres, and J. M. Pereira de Godoy Prevalence of Anticardiolipin Antibodies in Peripheral Arterial Thrombosis Angiology, June 1, 2000; 51(6): 473 - 477. [Abstract] [PDF]
|
|
|
|
|
|
M Bijl, J Brouwer, and G G. Kallenberg Grand Rounds from International Lupus Centres Cardiac abnormalities in SLE: pancarditis Lupus, May 1, 2000; 9(4): 236 - 240. [Abstract] [PDF]
|
|
|
|
 |
|
 L. I. Kupferwasser, G. Hafner, S. Mohr-Kahaly, R. Erbel, J.u. Meyer, and H. Darius The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1365 - 1371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Morelli, C Perrone, and M Paroli Recurrent cerebral infarctions in polyarteritis nodosa with circulating antiphospholipid antibodies and mitral valve disease Lupus, January 1, 1998; 7(1): 51 - 52. [Abstract] [PDF]
|
|
|
|
|
|
A. Bengtsson, B. Zoller, P. de Frutos, B. Dahlback, and G. Sturfelt Factor V:Q506 mutation and anticardiolipin antibodies in systemic lupus erythematosus Lupus, December 1, 1996; 5(6): 598 - 601. [Abstract] [PDF]
|
|
|
|
 |
|
 C. A. Roldan, B. K. Shively, and M. H. Crawford An Echocardiographic Study of Valvular Heart Disease Associated with Systemic Lupus Erythematosus N. Engl. J. Med., November 7, 1996; 335(19): 1424 - 1430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ziporen, I. Goldberg, M. Arad, M. Hojnik, J. Ordi-Ros, A. Afek, M. Blank, Y. Sandbank, M. Vilardell-Tarres, I. de Torres, et al. Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves Lupus, June 1, 1996; 5(3): 196 - 205. [Abstract] [PDF]
|
|
|
|
|
|
M. Hojnik, J. George, L. Ziporen, and Y. Shoenfeld Heart Valve Involvement (Libman-Sacks Endocarditis) in the Antiphospholipid Syndrome Circulation, April 15, 1996; 93(8): 1579 - 1587. [Abstract] [Full Text]
|
|
|
|
|
|
R. Garcia-Torres, M-C. Amigo, A. de la Rosa, A. Moron, and P. Reyes Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings Lupus, February 1, 1996; 5(1): 56 - 61. [Abstract] [PDF]
|
|
|
|
|
|
S. Morelli, C. Perrone, and G. Valesini Tricuspid Valve Steno-Insufficiency in Systemic Lupus Erythematosus Lupus, August 1, 1995; 4(4): 318 - 320. [Abstract] [PDF]
|
|
|
|
|
|
S.A. Abraham and K.K. Hansen Case 11-1995- A 39-year-old man with chronic renal failure, aortic regurgitation, and a calcified mass about the aortic root N. Engl. J. Med., April 13, 1995; 332(15): 1015 - 1022. [Full Text] [PDF]
|
|
|
|
|
|
S. Levitsky and V. Nickeleit Case 4-1995- A 26-year-old woman with recurrent angina after a triple coronary-artery bypass graft N. Engl. J. Med., February 9, 1995; 332(6): 380 - 386. [Full Text] [PDF]
|
|
|
|
|
|
P. R.J. Ames Medical Perspective Antiphospholipid Antibodies, Thrombosis and Atherosclerosis in Systemic Lupus Erythematosus: a Unifying 'Membrane Stress Syndrome' Hypothesis Lupus, October 1, 1994; 3(5): 371 - 377. [PDF]
|
|
|
|
|
|
R. L. Brey Stroke Prevention in Patients with Antiphospholipid Antibodies Lupus, August 1, 1994; 3(4): 299 - 302. [PDF]
|
|
|
|
|
|
J.L. Vianna, S. Trotter, M.A. Khamashta, S. Chikte, E. Olsen, and G.R.V. Hughes The Heart and Antiphospholipid Antibodies in MRL-lpr/lpr Mice Lupus, December 1, 1992; 1(6): 357 - 361. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Galve, J. Ordi, J. Barquinero, A. Evangelista, M. Vilardell, and J. Soler-Soler Valvular Heart Disease in the Primary Antiphospholipid Syndrome Ann Intern Med, February 15, 1992; 116(4): 293 - 298. [Abstract] [PDF]
|
|
|
|
|
|
R. Cervera, M. A. Khamashta, J. Font, P. A. Reyes, J. L. Vianna, A. Lopez-Soto, M.-C. Amigo, R. A. Asherson, M. Azqueta, C. Pare, et al. High Prevalence of Significant Heart Valve Lesions in Patients with the 'Primary' Antiphospholipid Syndrome Lupus, November 1, 1991; 1(1): 43 - 47. [Abstract] [PDF]
|
|